SHAPERON INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,536 KRW | -4.24% |
|
-12.58% | -59.15% |
| Jun. 10 | Shaperon and Dong-A St Sign MOU for Nanobody-Based New Drug Development | CI |
| Mar. 18 | Shaperon Enrolls its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel' | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SHAPERON INC. | Bio Therapeutic Drugs | -4.24% | -12.58% | -59.15% | -65.29% | - | 26.73M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- A378800 Stock
- Charts Shaperon Inc.
- Comparison Chart
